China OTC Industry Competitive Strategy and Investment Profitability Analysis Report 2023-2030.
Publisher]: Zhongying Xinhe Research Network.
The content part is abridged and detailed, please refer to the full information published by Zhongying Xinhe Research Network!】
Chapter 1 Overview of Over-the-Counter (OTC) Drugs.
1.1 Introduction to OTC.
1.1.1 Definition of OTC.
1.1.2 Features of OTC.
1.1.3 Main types of OTC drugs.
1.1.4 Difference Between Over-the-Counter and Prescription Drugs.
1.2 Overview of OTC drug development.
1.2.1 Overview of OTC drug development.
1.2.2 Principles of OTC drug approval.
1.2.3 Characteristics of the OTC drug market.
1.2.4 OTC market cultivation form.
Chapter 2 Analysis of the development of China's pharmaceutical industry from 2020 to 2023.
2.1 Analysis of the development of China's pharmaceutical industry from 2020 to 2023.
2.1.1 Overview of industrial development.
2.1.2 Progress in technology research and development.
2.1.3. Development of industrial parks.
2.1.4 Industry Compensation Costs.
2.1.5. Industry development hotspots.
2.1.6 International Development of Traditional Chinese Medicine.
2.2 Analysis of China's pharmaceutical market from 2020 to 2023.
2.2.1 Market operation in 2021.
2.2.2 Market operation in 2022.
2.2.3 Market operation in 2023.
2.3 Analysis of competition in China's pharmaceutical market from 2020 to 2023.
2.3.1 International competition analysis.
2.3.2 Changes in the market landscape.
2.3.3 Progress of industry consolidation.
2.3.4. Industry transformation and upgrading.
2.4 Problems and development countermeasures of China's pharmaceutical industry.
2.4.1 Development constraints.
2.4.2 Development is in question.
2.4.3 Industry responses.
2.4.4 Development countermeasures for pharmaceutical companies.
Chapter 3 Analysis of China's Over-the-Counter (OTC) Industry from 2020 to 2023.
3.1 Overview of the development of China's over-the-counter (OTC) drug industry from 2020 to 2023.
3.1.1 Review of development history.
3.1.2 Market development situation.
3.1.3 Product development status.
3.1.4 Industry dynamics.
3.1.5 Market development potential.
3.2 Analysis of China's over-the-counter (OTC) market landscape from 2020 to 2023.
3.2.1 Business landscape in 2021.
3.2.2 Product landscape in 2022.
3.2.3 E-commerce channels in 2023.
3.2.4 Competitive dynamics in 2023.
3.2.5. Intensified competition among enterprises.
3.3 Over-the-counter (OTC) product packaging analysis.
3.3.1 Pharmaceutical packaging advertising function.
3.3.2 The need for pharmaceutical packaging innovation.
3.3.3. Blind spot in drug packaging competition.
3.3.4. Direction of pill box packaging design.
3.4 Comparison of market characteristics of over-the-counter drugs and prescription drugs.
3.4.1 Policies and regulations.
3.4.2 R&D system.
3.4.3 Market structure and competitive strategy.
3.5 Problems in the development of the over-the-counter (OTC) drug industry.
3.5.1 Problems in drug registration.
3.5.2 The dilemma of OTC drug conversion.
3.5.3 Major issues with drug pricing.
3.5.4 Constraints on the development of local OTCs.
3.5.5 The crowdfunding dilemma of local OTCs.
3.6 Recommendations for the development of China's over-the-counter (OTC) industry.
3.6.1 OTC drug registration recommendations.
3.6.2 Recommendations for OTC conversion work.
3.6.3 OTC pricing policy recommendations.
3.6.4 OTC industry cross-border advice.
Chapter 4 2020-2023 Cold Medication Market Development Analysis.
4.1 Overview of the development of China's cold medicine industry.
4.1.1. Consumption characteristics of the industry.
4.1.2 Characteristics of industry operation.
4.1.3 Analysis of influencing factors.
4.2 Analysis of cold medicine market development from 2020 to 2023.
4.2.1. Market development scale.
4.2.2 Market competition.
4.2.3. Enterprise competition pattern.
4.2.4. Regional market development.
4.3 Cold Medicine Market Segment Analysis, 2020-2023.
4.3.1. The development status of the Banlangen market.
4.3.2 Oral liquid market development situation.
4.3.3 Children's cold medicine market size.
4.4 Problems and development countermeasures in the cold medicine market.
4.4.1. The market should not be over-segmented.
4.4.2. Analysis of market development strategy.
4.4.3. Problems and suggestions in the market.
Chapter 5 Analysis of China's Vitamin Market Development from 2020 to 2023.
5.1 Overview of the development of the vitamin market.
5.1.1 Overview of vitamins.
5.1.2 Product consumption characteristics.
5.1.3 Analysis of the current market situation.
5.1.4 Market competition pattern.
5.2 Analysis of vitamin exports, 2020-2023.
5.2.1 Export markets in 2021.
5.2.2 Export markets in 2022.
5.2.3 Export markets in 2023.
5.2.4 India imposes anti-dumping duties.
5.3 2020-2023 vitamin segment market development analysis.
5.3.1 Vitamin A Market Analysis.
5.3.2 Vitamin B3 Market Analysis.
5.3.3 Vitamin B4 Market Analysis.
5.3.4 Vitamin C Market Analysis.
5.3.5 Vitamin E Market Analysis.
5.4 Vitamin market development strategy and prospect analysis.
5.4.1 Marketing Strategy.
5.4.2 Industry development prospects.
Chapter 6 Other OTC Drug Market Segments, 2020-2023.
6.1 2020-2023** Drug Market Development Analysis.
6.1.1 End market size.
6.1.2 End market structure.
6.1.3 Segment size.
6.1.4. Enterprise Competitive Landscape.
6.2 Antipyretic analgesics market development analysis, 2020-2023.
6.2.1. Advantages in the development of the domestic market.
6.2.2 Analysis of the export scale of the market.
6.2.3 Children's Medicines Market Size.
6.3 Analysis of the development of the cardiovascular and cerebrovascular drugs market from 2020 to 2023.
6.3.1 Market development situation.
6.3.2 Market development scale.
6.3.3 RaaS market size
6.3.4. Enterprise development trends.
6.4 2020-2023** Drug Market Development Analysis.
6.4.1 **Competitive landscape of the drug market.
6.4.2 **Inflammation drug market size.
6.4.3 **Competitive landscape of inflammatory medications.
6.4.4 **Drug market size**.
Chapter 7 Over-the-Counter (OTC) Marketing Analysis, 2020-2023.
7.1 Overview of OTC Marketing.
7.1.1 Marketing characteristics.
7.1.2 Marketing channel model.
7.1.3. Market strategy model.
7.1.4 Marketing development direction.
7.2 OTC market consumer marketing analysis.
7.2.1 Product consumption characteristics.
7.2.2 Market Consumer Behavior.
7.2.3 Consumer psychology in the market.
7.2.4 Consumer Marketing Analytics.
7.3 OTC Advertising Marketing Analysis.
7.3.1 The role of OTC advertising and marketing.
7.3.2 OTC advertising marketing key.
7.3.3 Market advertising and marketing dilemma.
7.3.4 OTC Advertising Marketing Strategies.
7.3.5 Marketing Balance Strategy.
7.3.6 Product Advertising Innovation Strategy.
7.4 OTC brand marketing.
7.4.1 OTC market brand marketing.
7.4.2 Key factors in brand marketing.
7.4.3 Brand Marketing Implementation Guidelines.
7.4.4 Brand marketing is challenging.
7.4.5. Brand terminal price maintenance strategy.
7.5 OTC Marketing Strategies.
7.5.1 Marketing channel marketing strategy.
7.5.2. Analysis of market operation strategy.
7.5.3. Product operation marketing strategy.
7.5.4. Product terminal marketing strategy.
7.5.5 Marketing Strategy Trends.
7.5.6 Product marketing development trends.
Chapter 8 Analysis of the development of China's pharmaceutical retail industry from 2020 to 2023.
8.1 Overview of China's pharmaceutical retail development from 2020 to 2023.
8.1.1. The development environment of pharmaceutical retail.
8.1.2 Pharmaceutical retail competition landscape.
8.1.3 Opportunities for the development of pharmaceutical retail.
8.1.4 Pharmaceutical retail faces challenges.
8.2 The development scale of China's pharmaceutical retail market from 2020 to 2023.
8.2.1 Pharmaceutical retail market size.
8.2.2 The scale of drug circulation in 2021.
8.2.3 The scale of drug circulation in 2022.
8.2.4 Industry financing scale in 2022.
8.2.5 Pharmaceutical retail scale in 2022.
8.2.6 Pharmaceutical retail situation in 2023.
8.3 Analysis of China's pharmaceutical retail chain industry from 2020 to 2023.
8.3.1. Chain business model.
8.3.2 Chain operation conditions.
8.3.3 Industry competition situation.
8.3.4 Industry mergers and acquisitions boom.
8.3.5 Industry development trends.
8.4 Prospects for the pharmaceutical retail industry under the new medical reform.
8.4.1. The development direction of the medical reform program.
8.4.2 Changes in sales in the pharmaceutical industry.
8.4.3 The direction of local medical reform.
Chapter 9 Analysis of the development of China's pharmaceutical e-commerce industry from 2020 to 2023.
9.1 The development trend of China's pharmaceutical e-commerce industry from 2020 to 2023.
9.1.1 Industry competitive advantage.
9.1.2. Industry development situation.
9.1.3 Analysis of the policy environment.
9.1.4. Competitive operating models.
9.1.5 Competitive landscape analysis.
9.2 Analysis of the size of China's pharmaceutical e-commerce market from 2020 to 2023.
9.2.1 Market size 2021
9.2.2 Market size 2022
9.2.3 Market size 2023
9.3 Analysis of China's pharmaceutical e-commerce benchmarking enterprises.
9.3.1 Kenyi.com.
9.3.2 Ichishindo.
9.3.3 Zhencheng**.
9.3.4 Tmall Pharmacy.
9.4 Suggestions on the development strategy of China's pharmaceutical e-commerce.
9.4.1. Suggestions for business pain points.
9.4.2. Online and offline linkage.
9.4.3 Transformation of health management.
9.5 Analysis of the development prospect of China's pharmaceutical e-commerce.
9.5.1 Analysis of industry development trends.
9.5.2 Opportunities for the development of pharmaceutical e-commerce.
9.5.3 Prospects of "Internet + Medicine".
Chapter 10 Over-the-Counter (OTC) Key Companies Analysis from 2020 to 2023.
10.1 Harbin Pharmaceutical Group Co., Ltd. ***
10.1.1. Overview of enterprise development.
10.1.2. Analysis of business benefits.
10.1.3 Business operation analysis.
10.1.4 Analysis of the financial situation.
10.1.5 Future prospects.
10.2 Jiangzhong Pharmaceutical Co., Ltd. ***
10.2.1. Overview of enterprise development.
10.2.2. Analysis of business benefits.
10.2.3 Business operation analysis.
10.2.4 Analysis of the financial situation.
10.2.5 Future prospects.
10.3 China Resources Sanjiu Pharmaceutical Co., Ltd. ***
10.3.1. Overview of enterprise development.
10.3.2. Analysis of business benefits.
10.3.3 Business operation analysis.
10.3.4 Analysis of the financial situation.
10.3.5 Future prospects.
10.4 Yunnan Baiyao Group shares***
10.4.1. Overview of enterprise development.
10.4.2. Analysis of business benefits.
10.4.3 Business operation analysis.
10.4.4 Analysis of the financial situation.
10.4.5 Future prospects.
10.5 Shandong Dong'e Ejiao shares***
10.5.1. Overview of enterprise development.
10.5.2. Analysis of business benefits.
10.5.3 Business operation analysis.
10.5.4 Analysis of the financial situation.
10.5.5 Future prospects.
10.6 Ma Yinglong Pharmaceutical Group shares***
10.6.1. Overview of enterprise development.
10.6.2. Analysis of business benefits.
10.6.3 Business operation analysis.
10.6.4 Analysis of the financial situation.
10.6.5 Future prospects.
10.7 Beijing Tong Ren Tang Science and Technology Development Co., Ltd. ***
10.7.1. Overview of enterprise development.
10.7.2. Analysis of business benefits.
10.7.3 Business operation analysis.
10.7.4 Analysis of the financial situation.
10.7.5 Future prospects.
10.8 Comparative analysis of the financial affairs of listed companies.
10.8.1 Profitability analysis.
10.8.2 Growth ability analysis.
10.8.3 Operational Capability Analysis.
10.8.4 Solvency analysis.
11. 2023-2030 China Over-the-counter (OTC) Market Outlook.
11.1 Development prospects of China's pharmaceutical industry from 2023 to 2030.
11.1.1 The development priorities of the 14th Five-Year Plan.
11.1.2 Development trend of the pharmaceutical market.
11.1.3. The development space of the pharmaceutical market.
11.1.4. The development potential of the pharmaceutical market.
11.2 OTC market outlook trend analysis from 2023 to 2030.
11.2.1 The development direction of the OTC market.
11.2.2 The development trend of OTC enterprises.
11.2.3 OTC product development trends.
11.2.4 Analysis of China's OTC drug market size, 2023-2030.
Appendix: Appendix I: Drug Administration Law of the People's Republic of China.
Appendix II: Outline of the National Medical and Health Service System Plan.
Appendix III: Measures for the Classification of Prescription Drugs and Non-prescription Drugs (for Trial Implementation).
Appendix IV: Interim Provisions on the Administration of Circulation of Prescription Drugs and Non-prescription Drugs.
Table of Contents Chart 2020-2023 Nasdaq Biotech Index IBB Trend.
Chart A list of typical U.S. biopharmaceutical companies by market capitalization.
Diagram of the Obama Precision Medicine** case.
Chart 2016-2023 salary increase in pharmaceutical sub-industries.
Chart 2019-2023 salary increase in the pharmaceutical industry.
Chart Salary level of professional managers in first-tier cities in the pharmaceutical industry in 2023.
Chart Starting salaries of pharmaceutical graduates in 2023.
Chart 2023 Salary coefficient of cities in the pharmaceutical industry.
Chart: 2018-2021 growth rate of added value of medical industry and its proportion in the national industry.
Chart The completion of the main business income of the pharmaceutical industry in 2021.
Chart Total profit and profit margin of the pharmaceutical industry in 2021.
Chart Approved drugs for marketing in 2021.
Figure 2019-2022 cumulative growth rate and proportion of added value of pharmaceutical industry.
Chart The completion of the main business income of the pharmaceutical industry in 2022.
Chart Total profit and profit margin completion of the pharmaceutical industry in 2022.
Chart 2022 Completed review recommended approval for marketed drugs.
Chart The completion of the main business income of the pharmaceutical industry in 2023.
Chart The completion of the total profit of the pharmaceutical industry in 2023.
Chart: Changes in China's ranking in the global pharmaceutical market.
Chart 2021 comprehensive statistical ranking of China's OTC drug manufacturers.
Chart 2021 Comprehensive statistical ranking of China's OTC drug products (chemical drugs).
Chart 2021 Comprehensive statistical ranking of China's OTC drug products (proprietary Chinese medicines).
Chart Top 30 OTC drug brands in the pharmaceutical retail market in 2022.
Chart: Sales of five categories of Tmall Pharmacy in 2023.
Chart: 2023 Tmall Pharmacy OTC drug key sub-industries.
Chart 2023 Tmall Pharmacy Key Sales.
Chart 2023 Tmall Pharmacy Key Sales.
Chart 2023 Tmall Pharmacy Key OTC Drug Sales
Chart 2014-2021 China's cold medicine market size by category.
Chart 2023 Cold Medicine Market Competitive Landscape by Companies.
Chart 2016-2021 total cold medicine sales scale and growth in Beijing, Shanghai and Guangzhou.
Figure Distribution of cold medicines in Beijing, Shanghai and Guangzhou in 2021.
Chart: Distribution of cold medicine medication subjects in Beijing, Shanghai and Guangzhou in 2021.
Chart The concentration of the cold medicine market in Beijing, Shanghai and Guangzhou in 2021.
Chart 2021 Children's cold medicine market concentration in Beijing, Shanghai and Guangzhou.
Chart: The share and growth rate of the top five cold medicine brands in Beijing, Shanghai and Guangzhou in 2021.
Chart: The top five cold medicine companies in Beijing, Shanghai and Guangzhou in 2021.
Chart: The top five cold medicine manufacturers and their shares in Beijing, Shanghai and Guangzhou in 2021.
Chart Distribution of total cold medicine dosage forms in Beijing, Shanghai and Guangzhou in 2021.
Figure 2012-2023 scale of cold medication in children.
Chart Major brands of children's cold and fever reducers.
Chart Health care multivitamin products with good sales and relatively high popularity in the domestic market.
Chart Key considerations for consumers when choosing a multivitamin product.
Chart How much vitamins** changed in 2022.
Chart 2022 contribution to changes in the cost of vitamin consumption.
Chart Reasons why vitamin varieties are attracting attention from the audience in 2022.
Chart The degree of attention paid to hot events in the vitamin industry in 2022.
Chart 2022 Vitamin Consumption Cost** Range.
Chart 2022 Inventory usage time before and after inventory cycle adjustment.
Chart Vitamin A market in 2023**.
Chart Vitamin B3 market in 2023**
Chart Vitamin B4 market in 2023**
Chart Vitamin C market in 2023**
Chart Vitamin E market in 2023**
Figure 2020-2022 ** Total market size of disease drugs.
Chart 2020-2022** The five major terminal market shares of drug use.
Chart 2020-2022 ** Disease Drug Market Chemical Drugs Chinese Patent Medicine Market Share.
Chart 2020-2022 ** OTC RX market share of the disease drug market.
Chart 2020-2022 sales share of ** disease drugs by category.
Chart 2020-2022 ** Top 10 Generic Names for Disease Drugs Sales Share.
Chart 2020-2022 ** sales share of the top 10 products for disease drugs.
Chart 2020-2022 ** sales share of the top 10 manufacturers of disease drugs.
Chart China's paracetamol export scale in 2023.
Chart Composition of paracetamol export enterprises in China in 2023.
Figure Scale of antipyretic analgesics in children, 2011-2023.
Chart Major brands of antipyretic analgesics for children.
Figure 2017-2022 Cardiovascular and Cerebrovascular Drugs Market Size Analysis.
Chart Market share of various cardiovascular and cerebrovascular drugs.
Chart 2021**Top 10 drug lists
Chart **Competitive landscape of the inflammatory drugs market.
Chart **Brand competition landscape in the inflammation drugs market.
Diagram Schematic diagram of China's OTC marketing channel model portfolio.
Chart Top 30 retail enterprises in total sales in 2022
Chart: 2022 ranking of retail sales of pharmacies in major cities in China.
Chart Market share of major OTC drug categories from 2019 to 2022.
Chart Sales scale of the pharmaceutical circulation industry from 2016 to 2021.
Chart 2021 industry-wide sales category structure.
Chart Category structure of retail pharmacies in typical sample cities in 2021.
Chart Ownership structure of main business income of pharmaceutical circulation enterprises above designated size in 2021.
Chart Ownership structure of total profit of pharmaceutical circulation enterprises above designated size in 2021.
Chart 2021 Commodity distribution structure of pharmaceutical wholesale direct reporting enterprises.
Chart 2021 logistics cost structure of pharmaceutical wholesale direct reporting enterprises.
Chart The main business income of pharmaceutical wholesale enterprises of different sizes accounted for the total size of the national market in the same period.
Figure Number of retail pharmacies, 2016-2020.
Chart Sales trend of pharmaceutical distribution industry from 2017 to 2022.
Chart 2022 industry-wide sales category structure.
Chart Category structure of retail pharmacies in typical sample cities in 2022.
Chart Distribution of the ownership structure of the main business income of pharmaceutical circulation enterprises in 2022.
Chart Distribution of total profit ownership structure of pharmaceutical distribution enterprises in 2022.
Chart 2022 Commodity Distribution Structure of Pharmaceutical Wholesale Direct Reporting Enterprises.
Chart 2022 logistics cost structure of pharmaceutical wholesale direct reporting enterprises.
Chart: Number of enterprises with Internet drug trading service qualifications from 2020 to 2022.
Figure 2018-2022 Retail Drugs Non-Pharmaceutical Scale.
Chart 2018-2022 OTC RX scale of retail drugs.
Chart 2018-2022 Retail Chemical Drugs Scale of Proprietary Chinese Medicines.
Chart 2018-2022 retail non-pharmaceutical segment size.
Chart 2020-2022 OTC category ranking TOP20
Chart 2020-2022 RX Category Top 20
Figure 2020-2022 sales scale and growth rate of sample cities (1).
Figure 2020-2022 sales scale and growth rate of sample cities (2).
Figure 2020-2022 sales scale and growth rate of sample cities (3).
Chart 2023 Yixintang M&A list.
Chart 2023 list of mergers and acquisitions by ordinary people.
Chart List of mergers and acquisitions of Yifeng Pharmacy in 2023.
Diagram Pharmaceutical e-commerce reconstructs the ** chain process.
Chart Policies related to pharmaceutical e-commerce.
Chart 2021 domestic drug terminal sales product pattern.
Chart Domestic drug terminal revenue pattern in 2021.
Chart Comparison of the development environment of online pharmacies at home and abroad.
Chart Domestic pharmaceutical e-commerce business model.
Chart Platform-based pharmaceutical B2C business model.
Chart: Pharmaceutical Internet retail landscape.
Chart: Category share of Tmall Pharmacy.
Chart: Category share of pharmaceutical B2C official website market.
Chart The top 10 brands in sales of Tmall Pharmacy on "Double 11" in 2021.
Chart Comparison of profitability of pharmaceutical e-commerce at home and abroad.
Chart Comparison of pharmaceutical e-commerce self-operated model and platform model.
Chart The B2C retail landscape of domestic pharmaceutical e-commerce in 2021.
Chart Comparison of Tmall pharmaceutical product category share.
Chart Comparison of product category share of other pharmaceutical B2C official websites.
Chart Approval of pharmaceutical e-commerce licenses in 2023.
Chart Comparison of the profitability of online pharmacies in China and offline pharmacies and online pharmacies in the United States.
Chart From 2017 to 2022, the scale of China's pharmaceutical e-commerce market accounted for the proportion of e-commerce, pharmaceutical retail, and pharmaceutical market size.
Chart China's pharmaceutical e-commerce transaction scale from 2017 to 2022.
Figure Number of online pharmacies in China from 2017 to 2022.
Chart: The development history of Jianyi.com.
Chart 2022 Yixintang's operating income.
Diagram Health solutions based on CRM vs. OTO.
Chart Development trend of pharmaceutical e-commerce industry.
Chart Choices made by users when they are unwell.
Chart 2018-2023 mHealth market size and growth rate.
Chart 2021 mobile health app volume ranking.
Chart: The liberalization of drug policies and the size of the space for pharmaceutical e-commerce.
Chart 2020-2023 total assets and net assets of Harbin Pharmaceutical Group.
Chart 2020-2022 operating income and net profit of Harbin Pharmaceutical Group.
Chart 2023 Harbin Pharmaceutical Group shares*** operating income and net profit.
Chart 2020-2022 cash flow of Harbin Pharmaceutical Group shares.
Chart 2023 cash flow of Harbin Pharmaceutical Group shares.
Chart 2022 Harbin Pharmaceutical Group Co., Ltd.*** main business income by industry, product and region.
Chart 2020-2022 Harbin Pharmaceutical Group shares*** growth capacity.
Chart 2023 Harbin Pharmaceutical Group's share growth capacity.
Chart 2020-2022 short-term solvency of Harbin Pharmaceutical Group shares.
Chart 2023 Harbin Pharmaceutical Group shares*** short-term solvency.
Chart 2020-2022 Harbin Pharmaceutical Group shares*** long-term solvency.
Chart 2023 Harbin Pharmaceutical Group shares*** long-term solvency.
Chart 2020-2022 Harbin Pharmaceutical Group shares*** operating capacity.
Chart 2023 Harbin Pharmaceutical Group's operating capacity.
Chart 2020-2022 Harbin Pharmaceutical Group shares*** profitability.
Chart 2023 Harbin Pharmaceutical Group shares*** profitability.
Chart 2020-2023 total assets and net assets of Jiangzhong Pharmaceutical Co., Ltd.
Chart 2020-2022 Jiangzhong Pharmaceutical Co., Ltd.*** operating income and net profit.
Chart 2023 Jiangzhong Pharmaceutical Co., Ltd.*** operating income and net profit.
Chart 2020-2022 Jiangzhong Pharmaceutical Co., Ltd.*** cash flow.
Chart 2023 Jiangzhong Pharmaceutical Co., Ltd.*** cash flow.
Chart In 2022, the main business income of Jiangzhong Pharmaceutical Co., Ltd. is divided into industries, products and regions.
Chart 2020-2022 Jiangzhong Pharmaceutical Co., Ltd.'s growth capacity.
Chart 2023 Jiangzhong Pharmaceutical Co., Ltd.'s growth capacity.
Chart 2020-2022 Jiangzhong Pharmaceutical Co., Ltd.*** short-term solvency.
Chart 2023 Jiangzhong Pharmaceutical Co., Ltd.*** short-term solvency.
Chart 2020-2022 long-term solvency of Jiangzhong Pharmaceutical Co., Ltd.
Chart 2023 Jiangzhong Pharmaceutical Co., Ltd.*** long-term solvency.
Chart 2020-2022 Jiangzhong Pharmaceutical Co., Ltd.'s operating capacity.
Chart 2023 Jiangzhong Pharmaceutical Co., Ltd.*** operating capacity.
Chart 2020-2022 Jiangzhong Pharmaceutical Co., Ltd. *** profitability.
Chart 2023 Jiangzhong Pharmaceutical Co., Ltd. *** profitability.
Chart 2020-2023 China Resources Sanjiu Pharmaceutical Co., Ltd.*** total assets and net assets.
Chart 2020-2022 China Resources Sanjiu Pharmaceutical Co., Ltd.*** operating income and net profit.
Chart 2023 China Resources Sanjiu Pharmaceutical Co., Ltd.*** operating income and net profit.
Chart 2020-2022 cash flow of China Resources Sanjiu Pharmaceutical shares.
Chart 2023 cash flow of China Resources Sanjiu Pharmaceutical shares.
Chart 2022 China Resources Sanjiu Pharmaceutical Co., Ltd.*** main business income by industry, product and region.
Chart 2020-2022 China Resources Sanjiu Pharmaceutical Co., Ltd.'s growth capacity.
Chart 2023 China Resources Sanjiu Pharmaceutical Co., Ltd.'s growth capacity.
Chart 2020-2022 China Resources Sanjiu Pharmaceutical Co., Ltd.*** short-term solvency.
Chart 2023 China Resources Sanjiu Pharmaceutical Co., Ltd.*** short-term solvency.
Chart 2020-2022 China Resources Sanjiu Pharmaceutical Co., Ltd.*** long-term solvency.
Chart 2023 China Resources Sanjiu Pharmaceutical Co., Ltd.*** long-term solvency.
Chart 2020-2022 China Resources Sanjiu Pharmaceutical Co., Ltd.*** operating capacity.
Chart 2023 China Resources Sanjiu Pharmaceutical Co., Ltd.*** operating capacity.
Chart 2020-2022 profitability of China Resources Sanjiu Pharmaceutical Co., Ltd.
Chart 2023 China Resources Sanjiu Pharmaceutical Co., Ltd.*** profitability.
Chart 2020-2023 Yunnan Baiyao Group shares*** total assets and net assets.
Chart 2020-2022 Yunnan Baiyao Group shares*** operating income and net profit.
Chart 2023 Yunnan Baiyao Group shares*** operating income and net profit.
Chart 2020-2022 Yunnan Baiyao Group shares*** cash flow.
Chart 2023 Yunnan Baiyao Group shares*** cash flow.
Chart 2022 Yunnan Baiyao Group Co., Ltd.*** main business income by industry, product and region.
Chart 2020-2022 Yunnan Baiyao Group shares*** growth capacity.
Chart 2023 Yunnan Baiyao Group shares*** growth capacity.
Chart 2020-2022 Yunnan Baiyao Group shares*** short-term solvency.
Chart 2023 Yunnan Baiyao Group shares*** short-term solvency.
Chart 2020-2022 Yunnan Baiyao Group shares*** long-term solvency.
Chart 2023 Yunnan Baiyao Group shares*** long-term solvency.
Chart 2020-2022 Yunnan Baiyao Group shares*** operating capacity.
Chart 2023 Yunnan Baiyao Group shares*** operating capacity.
Chart 2020-2022 Yunnan Baiyao Group shares*** profitability.
Chart 2023 Yunnan Baiyao Group shares*** profitability.
Chart 2020-2023 total assets and net assets of Shandong Dong'e Ejiao shares.
Chart 2020-2022 Shandong Dong'e Ejiao Co., Ltd. *** operating income and net profit.
Chart 2023 Shandong Dong'e Ejiao Co., Ltd.*** operating income and net profit.
Chart 2020-2022 cash flow of Shandong Dong'e Ejiao shares.
Chart 2023 cash flow of Shandong Dong'e Ejiao shares.
Chart In 2022, the main business income of Shandong Dong'e Ejiao Co., Ltd. is divided into industries, products and regions.
Chart 2020-2022 Shandong Dong'e Ejiao Co., Ltd.'s growth capacity.
Chart 2023 Shandong Dong'e Ejiao Co., Ltd.'s growth capacity.
Chart 2020-2022 Shandong Dong'e Ejiao shares*** short-term solvency.
Chart 2023 Shandong Dong'e Ejiao shares*** short-term solvency.
Chart 2020-2022 Shandong Dong'e Ejiao shares *** long-term solvency.
Chart 2023 Shandong Dong'e Ejiao shares*** long-term solvency.
Chart 2020-2022 Shandong Dong'e Ejiao Co., Ltd. *** operating capacity.
Chart 2023 Shandong Dong'e Ejiao Co., Ltd.'s operational capacity.
Chart 2020-2022 profitability of Shandong Dong'e Ejiao shares.
Chart 2023 Shandong Dong'e Ejiao shares*** profitability.
Chart 2020-2023 total assets and net assets of Ma Yinglong Pharmaceutical Group shares.
Chart 2020-2022 Ma Yinglong Pharmaceutical Group shares*** operating income and net profit.
Chart 2023 Ma Yinglong Pharmaceutical Group shares*** operating income and net profit.
Chart 2020-2022 Ma Yinglong Pharmaceutical Group shares*** cash flow.
Chart 2023 Cash flow of Ma Yinglong Pharmaceutical Group shares.
Chart 2022 Ma Yinglong Pharmaceutical Group Co., Ltd.*** main business income by industry, product and region.
Chart 2020-2022 Ma Yinglong Pharmaceutical Group shares growth capacity.
Chart 2023 Ma Yinglong Pharmaceutical Group's share growth capacity.
Chart 2020-2022 Ma Yinglong Pharmaceutical Group shares*** short-term solvency.
Chart 2023 Ma Yinglong Pharmaceutical Group shares*** short-term solvency.
Chart 2020-2022 Ma Yinglong Pharmaceutical Group shares *** long-term solvency.
Chart 2023 Ma Yinglong Pharmaceutical Group shares*** long-term solvency.
Chart 2020-2022 Ma Yinglong Pharmaceutical Group shares *** operating capacity.
Chart 2023 Ma Yinglong Pharmaceutical Group shares*** operating capacity.
Chart 2020-2022 Ma Yinglong Pharmaceutical Group shares*** profitability.
Chart 2023 Ma Yinglong Pharmaceutical Group shares*** profitability.
Chart 2020-2023 Beijing Tong Ren Tang shares*** total assets and net assets.
Chart 2020-2022 Beijing Tong Ren Tang Co., Ltd.*** operating income and net profit.
Chart 2023 Beijing Tong Ren Tang shares*** operating income and net profit.
Chart 2020-2022 cash flow of Beijing Tong Ren Tang shares.
Chart 2023 cash flow of Beijing Tong Ren Tang shares.
Chart 2022 Beijing Tong Ren Tang Co., Ltd.*** main business income by industry, product and region.
Chart 2020-2022 Beijing Tong Ren Tang shares*** growth capacity.
Chart 2023 Beijing Tong Ren Tang shares*** growth capacity.
Chart 2020-2022 Beijing Tong Ren Tang shares*** short-term solvency.
Chart 2023 Beijing Tong Ren Tang shares*** short-term solvency.
Chart 2020-2022 Beijing Tong Ren Tang shares*** long-term solvency.
Chart 2023 Beijing Tong Ren Tang shares*** long-term solvency.
Chart 2020-2022 Beijing Tong Ren Tang Co., Ltd.*** operating capacity.
Chart 2023 Beijing Tong Ren Tang shares*** operating capacity.
Chart 2020-2022 profitability of Beijing Tong Ren Tang shares.
Chart 2023 Beijing Tong Ren Tang shares*** profitability.
Chart Analysis of profitability indicators of listed companies in the OTC drug industry in 2021.
Chart Analysis of the growth capacity indicators of listed companies in the OTC drug industry in 2023.
Chart Analysis of the growth capacity indicators of listed companies in the OTC drug industry in 2022.
Chart Analysis of the growth ability indicators of listed companies in the OTC drug industry in 2021.
Chart Analysis of the operating capacity indicators of listed companies in the OTC drug industry in 2022.
Chart Analysis of the operating capacity indicators of listed companies in the OTC drug industry in 2021.
Chart Analysis of solvency indicators of listed companies in the OTC drug industry in 2023.
Chart Analysis of solvency indicators of listed companies in the OTC drug industry in 2022.
Chart Analysis of solvency indicators of listed companies in the OTC drug industry in 2021.
Chart China's OTC drug market size 2023-2030**.
Chart Main indicators of resource element allocation in the national medical and health service system in 2023.
Chart Health care system.